Related Experiment Video

Updated: Dec 18, 2025

Improved Home Blood Pressure Control by CT-guided Ozone-mediated Renal Denervation for Patients with Resistant Hypertension
04:37

Improved Home Blood Pressure Control by CT-guided Ozone-mediated Renal Denervation for Patients with Resistant Hypertension

Published on: June 6, 2025

576

DOAC dose adjustment in renal impairment

    Drug and Therapeutics Bulletin
    |June 18, 2020
    PubMed

    Insights

    Patients with atrial fibrillation experiencing declining renal function often require reduced oral anticoagulation doses. This study highlights the importance of monitoring kidney function to adjust anticoagulant therapy safely and effectively.

    Area of Science:

    • Cardiology
    • Nephrology
    • Pharmacology

    Background:

    • Atrial fibrillation (AF) is a common arrhythmia requiring anticoagulation.
    • Renal function decline is prevalent in patients with AF.
    • Oral anticoagulants (OACs) require dose adjustments based on renal function.

    Purpose of the Study:

    • To investigate the association between declining renal function and OAC dose reduction in AF patients.
    • To determine the frequency of OAC dose adjustments due to worsening kidney function.
    • To assess the clinical implications of renal function changes on OAC therapy.

    Main Methods:

    • Retrospective analysis of a cohort of AF patients.
    • Evaluation of changes in estimated glomerular filtration rate (eGFR).
    • Assessment of OAC dose modifications over time.

    Main Results:

    • A significant proportion of AF patients experienced a decline in renal function.
    • Declining renal function was associated with a higher likelihood of OAC dose reduction.
    • Specific OACs and patient characteristics influenced the rate of dose adjustment.

    Conclusions:

    • Monitoring renal function is crucial for managing OAC therapy in AF patients.
    • Dose adjustments are frequently necessary as renal function deteriorates.
    • Optimizing OAC dosing based on renal status may improve patient outcomes.

    Keywords:
    healthcare quality, access, and evaluationimmune system diseases

    More Related Videos

    Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS08:38

    Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS

    Published on: November 8, 2015

    17.3K
    X-ray Dose Reduction through Adaptive Exposure in Fluoroscopic Imaging08:30

    X-ray Dose Reduction through Adaptive Exposure in Fluoroscopic Imaging

    Published on: September 11, 2011

    14.8K

    Related Concept Videos

    Renal Failure: Dose Adjustments01:11

    Renal Failure: Dose Adjustments

    In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
    Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
    However, dosage adjustments...
    347
    Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant01:25

    Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant

    In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
    143
    Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance01:25

    Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance

    In healthy individuals, serum creatinine levels remain stable due to a balance between its constant production—primarily from muscle metabolism—and renal excretion. Creatinine is freely filtered by the glomeruli, making it a valuable marker for estimating renal function. When the glomerular filtration rate (GFR) decreases, the kidneys can only eliminate less creatinine, causing serum levels to rise.Serum creatinine concentration is widely used to estimate creatinine clearance...
    116
    Drug Dosing: Geriatric Patients01:15

    Drug Dosing: Geriatric Patients

    Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
    157
    Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment01:08

    Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

    Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
    122
    Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

    Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

    Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area.
    110